Global Influenza Virus Vaccine (H1N1) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
LPI (LP Information)' newest research report, the “Influenza Virus Vaccine (H1N1) Industry Forecast” looks at past sales and reviews total world Influenza Virus Vaccine (H1N1) sales in 2022, providing a comprehensive analysis by region and market sector of projected Influenza Virus Vaccine (H1N1) sales for 2023 through 2029. With Influenza Virus Vaccine (H1N1) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Virus Vaccine (H1N1) industry.
This Insight Report provides a comprehensive analysis of the global Influenza Virus Vaccine (H1N1) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Virus Vaccine (H1N1) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Influenza Virus Vaccine (H1N1) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Virus Vaccine (H1N1) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Virus Vaccine (H1N1).
The global Influenza Virus Vaccine (H1N1) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Influenza Virus Vaccine (H1N1) players cover CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine and Changchun Changsheng Bio-Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Vaccine (H1N1) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Influenza Virus Vaccine (H1N1) market?
What factors are driving Influenza Virus Vaccine (H1N1) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Virus Vaccine (H1N1) market opportunities vary by end market size?
How does Influenza Virus Vaccine (H1N1) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
LPI (LP Information)' newest research report, the “Influenza Virus Vaccine (H1N1) Industry Forecast” looks at past sales and reviews total world Influenza Virus Vaccine (H1N1) sales in 2022, providing a comprehensive analysis by region and market sector of projected Influenza Virus Vaccine (H1N1) sales for 2023 through 2029. With Influenza Virus Vaccine (H1N1) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Virus Vaccine (H1N1) industry.
This Insight Report provides a comprehensive analysis of the global Influenza Virus Vaccine (H1N1) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Virus Vaccine (H1N1) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Influenza Virus Vaccine (H1N1) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Virus Vaccine (H1N1) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Virus Vaccine (H1N1).
The global Influenza Virus Vaccine (H1N1) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Influenza Virus Vaccine (H1N1) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Influenza Virus Vaccine (H1N1) players cover CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine and Changchun Changsheng Bio-Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Vaccine (H1N1) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Intramuscular Vaccine
- Nasal Spray Vaccine
- 3 To 10 Years Old
- 10 To 18 Years Old
- Above 18 Years Old
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL
- NVS(Novartis)
- Sanofi Pasteur
- Medimmune
- GSK
- Baxter
- Beijing Kexing Bio-Vaccine
- Hualan Bio-Vaccine
- Changchun Changsheng Bio-Technology
- Beijing Tiantan Bio-Products
- Jiangsu Yanshen Bio-Technology
- Zhejiang Tianyuan Bio-Pharmaceutical
- Dalian Yalifeng Bio-Pharmaceutical
- Sinopharm
What is the 10-year outlook for the global Influenza Virus Vaccine (H1N1) market?
What factors are driving Influenza Virus Vaccine (H1N1) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Virus Vaccine (H1N1) market opportunities vary by end market size?
How does Influenza Virus Vaccine (H1N1) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Country/Region, 2018, 2022 & 2029
2.2 Influenza Virus Vaccine (H1N1) Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.3 Influenza Virus Vaccine (H1N1) Sales by Type
2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2018-2023)
2.4 Influenza Virus Vaccine (H1N1) Segment by Application
2.4.1 3 To 10 Years Old
2.4.2 10 To 18 Years Old
2.4.3 Above 18 Years Old
2.4.4 Other
2.5 Influenza Virus Vaccine (H1N1) Sales by Application
2.5.1 Global Influenza Virus Vaccine (H1N1) Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA VIRUS VACCINE (H1N1) BY COMPANY
3.1 Global Influenza Virus Vaccine (H1N1) Breakdown Data by Company
3.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2018-2023)
3.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Company (2018-2023)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Company
3.4 Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Location Distribution
3.4.2 Players Influenza Virus Vaccine (H1N1) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA VIRUS VACCINE (H1N1) BY GEOGRAPHIC REGION
4.1 World Historic Influenza Virus Vaccine (H1N1) Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Virus Vaccine (H1N1) Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Virus Vaccine (H1N1) Sales Growth
4.4 APAC Influenza Virus Vaccine (H1N1) Sales Growth
4.5 Europe Influenza Virus Vaccine (H1N1) Sales Growth
4.6 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Growth
5 AMERICAS
5.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country
5.1.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
5.1.2 Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
5.2 Americas Influenza Virus Vaccine (H1N1) Sales by Type
5.3 Americas Influenza Virus Vaccine (H1N1) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region
6.1.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023)
6.1.2 APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023)
6.2 APAC Influenza Virus Vaccine (H1N1) Sales by Type
6.3 APAC Influenza Virus Vaccine (H1N1) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Virus Vaccine (H1N1) by Country
7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
7.2 Europe Influenza Virus Vaccine (H1N1) Sales by Type
7.3 Europe Influenza Virus Vaccine (H1N1) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Virus Vaccine (H1N1) by Country
8.1.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type
8.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1)
10.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
10.4 Industry Chain Structure of Influenza Virus Vaccine (H1N1)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Virus Vaccine (H1N1) Distributors
11.3 Influenza Virus Vaccine (H1N1) Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA VIRUS VACCINE (H1N1) BY GEOGRAPHIC REGION
12.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region
12.1.1 Global Influenza Virus Vaccine (H1N1) Forecast by Region (2024-2029)
12.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Virus Vaccine (H1N1) Forecast by Type
12.7 Global Influenza Virus Vaccine (H1N1) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 NVS(Novartis)
13.2.1 NVS(Novartis) Company Information
13.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 NVS(Novartis) Main Business Overview
13.2.5 NVS(Novartis) Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Medimmune
13.4.1 Medimmune Company Information
13.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medimmune Main Business Overview
13.4.5 Medimmune Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 Beijing Kexing Bio-Vaccine
13.7.1 Beijing Kexing Bio-Vaccine Company Information
13.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Beijing Kexing Bio-Vaccine Main Business Overview
13.7.5 Beijing Kexing Bio-Vaccine Latest Developments
13.8 Hualan Bio-Vaccine
13.8.1 Hualan Bio-Vaccine Company Information
13.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hualan Bio-Vaccine Main Business Overview
13.8.5 Hualan Bio-Vaccine Latest Developments
13.9 Changchun Changsheng Bio-Technology
13.9.1 Changchun Changsheng Bio-Technology Company Information
13.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changchun Changsheng Bio-Technology Main Business Overview
13.9.5 Changchun Changsheng Bio-Technology Latest Developments
13.10 Beijing Tiantan Bio-Products
13.10.1 Beijing Tiantan Bio-Products Company Information
13.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Beijing Tiantan Bio-Products Main Business Overview
13.10.5 Beijing Tiantan Bio-Products Latest Developments
13.11 Jiangsu Yanshen Bio-Technology
13.11.1 Jiangsu Yanshen Bio-Technology Company Information
13.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Yanshen Bio-Technology Main Business Overview
13.11.5 Jiangsu Yanshen Bio-Technology Latest Developments
13.12 Zhejiang Tianyuan Bio-Pharmaceutical
13.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
13.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview
13.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13.13 Dalian Yalifeng Bio-Pharmaceutical
13.13.1 Dalian Yalifeng Bio-Pharmaceutical Company Information
13.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Dalian Yalifeng Bio-Pharmaceutical Main Business Overview
13.13.5 Dalian Yalifeng Bio-Pharmaceutical Latest Developments
13.14 Sinopharm
13.14.1 Sinopharm Company Information
13.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sinopharm Main Business Overview
13.14.5 Sinopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Country/Region, 2018, 2022 & 2029
2.2 Influenza Virus Vaccine (H1N1) Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.3 Influenza Virus Vaccine (H1N1) Sales by Type
2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2018-2023)
2.4 Influenza Virus Vaccine (H1N1) Segment by Application
2.4.1 3 To 10 Years Old
2.4.2 10 To 18 Years Old
2.4.3 Above 18 Years Old
2.4.4 Other
2.5 Influenza Virus Vaccine (H1N1) Sales by Application
2.5.1 Global Influenza Virus Vaccine (H1N1) Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA VIRUS VACCINE (H1N1) BY COMPANY
3.1 Global Influenza Virus Vaccine (H1N1) Breakdown Data by Company
3.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2018-2023)
3.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Company (2018-2023)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Company
3.4 Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Location Distribution
3.4.2 Players Influenza Virus Vaccine (H1N1) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA VIRUS VACCINE (H1N1) BY GEOGRAPHIC REGION
4.1 World Historic Influenza Virus Vaccine (H1N1) Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Virus Vaccine (H1N1) Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Virus Vaccine (H1N1) Sales Growth
4.4 APAC Influenza Virus Vaccine (H1N1) Sales Growth
4.5 Europe Influenza Virus Vaccine (H1N1) Sales Growth
4.6 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Growth
5 AMERICAS
5.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country
5.1.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
5.1.2 Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
5.2 Americas Influenza Virus Vaccine (H1N1) Sales by Type
5.3 Americas Influenza Virus Vaccine (H1N1) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region
6.1.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023)
6.1.2 APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023)
6.2 APAC Influenza Virus Vaccine (H1N1) Sales by Type
6.3 APAC Influenza Virus Vaccine (H1N1) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Virus Vaccine (H1N1) by Country
7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
7.2 Europe Influenza Virus Vaccine (H1N1) Sales by Type
7.3 Europe Influenza Virus Vaccine (H1N1) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Virus Vaccine (H1N1) by Country
8.1.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type
8.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1)
10.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
10.4 Industry Chain Structure of Influenza Virus Vaccine (H1N1)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Virus Vaccine (H1N1) Distributors
11.3 Influenza Virus Vaccine (H1N1) Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA VIRUS VACCINE (H1N1) BY GEOGRAPHIC REGION
12.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region
12.1.1 Global Influenza Virus Vaccine (H1N1) Forecast by Region (2024-2029)
12.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Virus Vaccine (H1N1) Forecast by Type
12.7 Global Influenza Virus Vaccine (H1N1) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 NVS(Novartis)
13.2.1 NVS(Novartis) Company Information
13.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 NVS(Novartis) Main Business Overview
13.2.5 NVS(Novartis) Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Medimmune
13.4.1 Medimmune Company Information
13.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medimmune Main Business Overview
13.4.5 Medimmune Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 Beijing Kexing Bio-Vaccine
13.7.1 Beijing Kexing Bio-Vaccine Company Information
13.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Beijing Kexing Bio-Vaccine Main Business Overview
13.7.5 Beijing Kexing Bio-Vaccine Latest Developments
13.8 Hualan Bio-Vaccine
13.8.1 Hualan Bio-Vaccine Company Information
13.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hualan Bio-Vaccine Main Business Overview
13.8.5 Hualan Bio-Vaccine Latest Developments
13.9 Changchun Changsheng Bio-Technology
13.9.1 Changchun Changsheng Bio-Technology Company Information
13.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changchun Changsheng Bio-Technology Main Business Overview
13.9.5 Changchun Changsheng Bio-Technology Latest Developments
13.10 Beijing Tiantan Bio-Products
13.10.1 Beijing Tiantan Bio-Products Company Information
13.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Beijing Tiantan Bio-Products Main Business Overview
13.10.5 Beijing Tiantan Bio-Products Latest Developments
13.11 Jiangsu Yanshen Bio-Technology
13.11.1 Jiangsu Yanshen Bio-Technology Company Information
13.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Yanshen Bio-Technology Main Business Overview
13.11.5 Jiangsu Yanshen Bio-Technology Latest Developments
13.12 Zhejiang Tianyuan Bio-Pharmaceutical
13.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
13.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview
13.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13.13 Dalian Yalifeng Bio-Pharmaceutical
13.13.1 Dalian Yalifeng Bio-Pharmaceutical Company Information
13.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Dalian Yalifeng Bio-Pharmaceutical Main Business Overview
13.13.5 Dalian Yalifeng Bio-Pharmaceutical Latest Developments
13.14 Sinopharm
13.14.1 Sinopharm Company Information
13.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
13.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sinopharm Main Business Overview
13.14.5 Sinopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intramuscular Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2023)
Table 9. Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2018-2023)
Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2018-2023)
Table 14. Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Company (2018-2023) & (K Doses)
Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2018-2023)
Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2018-2023)
Table 19. Global Influenza Virus Vaccine (H1N1) Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution and Sales Area
Table 21. Players Influenza Virus Vaccine (H1N1) Products Offered
Table 22. Influenza Virus Vaccine (H1N1) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Influenza Virus Vaccine (H1N1) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Influenza Virus Vaccine (H1N1) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Influenza Virus Vaccine (H1N1) Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Influenza Virus Vaccine (H1N1) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 35. Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 37. Americas Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2018-2023)
Table 41. APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2018-2023)
Table 43. APAC Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 47. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 49. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Influenza Virus Vaccine (H1N1)
Table 58. Key Market Challenges & Risks of Influenza Virus Vaccine (H1N1)
Table 59. Key Industry Trends of Influenza Virus Vaccine (H1N1)
Table 60. Influenza Virus Vaccine (H1N1) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Influenza Virus Vaccine (H1N1) Distributors List
Table 63. Influenza Virus Vaccine (H1N1) Customer List
Table 64. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. CSL Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 80. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. NVS(Novartis) Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 84. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 85. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. NVS(Novartis) Main Business
Table 87. NVS(Novartis) Latest Developments
Table 88. Sanofi Pasteur Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 90. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. Sanofi Pasteur Main Business
Table 92. Sanofi Pasteur Latest Developments
Table 93. Medimmune Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 94. Medimmune Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 95. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Medimmune Main Business
Table 97. Medimmune Latest Developments
Table 98. GSK Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 100. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Baxter Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 104. Baxter Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 105. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 106. Baxter Main Business
Table 107. Baxter Latest Developments
Table 108. Beijing Kexing Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 109. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 110. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 111. Beijing Kexing Bio-Vaccine Main Business
Table 112. Beijing Kexing Bio-Vaccine Latest Developments
Table 113. Hualan Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 114. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 115. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 116. Hualan Bio-Vaccine Main Business
Table 117. Hualan Bio-Vaccine Latest Developments
Table 118. Changchun Changsheng Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 119. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 120. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 121. Changchun Changsheng Bio-Technology Main Business
Table 122. Changchun Changsheng Bio-Technology Latest Developments
Table 123. Beijing Tiantan Bio-Products Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 124. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 125. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 126. Beijing Tiantan Bio-Products Main Business
Table 127. Beijing Tiantan Bio-Products Latest Developments
Table 128. Jiangsu Yanshen Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 130. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 131. Jiangsu Yanshen Bio-Technology Main Business
Table 132. Jiangsu Yanshen Bio-Technology Latest Developments
Table 133. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 135. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 136. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 137. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 138. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 139. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 140. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 141. Dalian Yalifeng Bio-Pharmaceutical Main Business
Table 142. Dalian Yalifeng Bio-Pharmaceutical Latest Developments
Table 143. Sinopharm Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 144. Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 145. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 146. Sinopharm Main Business
Table 147. Sinopharm Latest Developments
Table 1. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intramuscular Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2023)
Table 9. Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2018-2023)
Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2018-2023)
Table 14. Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Company (2018-2023) & (K Doses)
Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2018-2023)
Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2018-2023)
Table 19. Global Influenza Virus Vaccine (H1N1) Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution and Sales Area
Table 21. Players Influenza Virus Vaccine (H1N1) Products Offered
Table 22. Influenza Virus Vaccine (H1N1) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Influenza Virus Vaccine (H1N1) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Influenza Virus Vaccine (H1N1) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Influenza Virus Vaccine (H1N1) Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Influenza Virus Vaccine (H1N1) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 35. Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 37. Americas Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2018-2023)
Table 41. APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2018-2023)
Table 43. APAC Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 47. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 49. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Influenza Virus Vaccine (H1N1)
Table 58. Key Market Challenges & Risks of Influenza Virus Vaccine (H1N1)
Table 59. Key Industry Trends of Influenza Virus Vaccine (H1N1)
Table 60. Influenza Virus Vaccine (H1N1) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Influenza Virus Vaccine (H1N1) Distributors List
Table 63. Influenza Virus Vaccine (H1N1) Customer List
Table 64. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. CSL Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 80. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. NVS(Novartis) Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 84. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 85. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. NVS(Novartis) Main Business
Table 87. NVS(Novartis) Latest Developments
Table 88. Sanofi Pasteur Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 90. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. Sanofi Pasteur Main Business
Table 92. Sanofi Pasteur Latest Developments
Table 93. Medimmune Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 94. Medimmune Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 95. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Medimmune Main Business
Table 97. Medimmune Latest Developments
Table 98. GSK Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 100. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Baxter Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 104. Baxter Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 105. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 106. Baxter Main Business
Table 107. Baxter Latest Developments
Table 108. Beijing Kexing Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 109. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 110. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 111. Beijing Kexing Bio-Vaccine Main Business
Table 112. Beijing Kexing Bio-Vaccine Latest Developments
Table 113. Hualan Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 114. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 115. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 116. Hualan Bio-Vaccine Main Business
Table 117. Hualan Bio-Vaccine Latest Developments
Table 118. Changchun Changsheng Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 119. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 120. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 121. Changchun Changsheng Bio-Technology Main Business
Table 122. Changchun Changsheng Bio-Technology Latest Developments
Table 123. Beijing Tiantan Bio-Products Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 124. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 125. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 126. Beijing Tiantan Bio-Products Main Business
Table 127. Beijing Tiantan Bio-Products Latest Developments
Table 128. Jiangsu Yanshen Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 130. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 131. Jiangsu Yanshen Bio-Technology Main Business
Table 132. Jiangsu Yanshen Bio-Technology Latest Developments
Table 133. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 135. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 136. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 137. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 138. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 139. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 140. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 141. Dalian Yalifeng Bio-Pharmaceutical Main Business
Table 142. Dalian Yalifeng Bio-Pharmaceutical Latest Developments
Table 143. Sinopharm Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 144. Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolios and Specifications
Table 145. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 146. Sinopharm Main Business
Table 147. Sinopharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Influenza Virus Vaccine (H1N1) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Virus Vaccine (H1N1) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intramuscular Vaccine
Figure 10. Product Picture of Nasal Spray Vaccine
Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2022
Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2023)
Figure 13. Influenza Virus Vaccine (H1N1) Consumed in 3 To 10 Years Old
Figure 14. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2018-2023) & (K Doses)
Figure 15. Influenza Virus Vaccine (H1N1) Consumed in 10 To 18 Years Old
Figure 16. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2018-2023) & (K Doses)
Figure 17. Influenza Virus Vaccine (H1N1) Consumed in Above 18 Years Old
Figure 18. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2018-2023) & (K Doses)
Figure 19. Influenza Virus Vaccine (H1N1) Consumed in Other
Figure 20. Global Influenza Virus Vaccine (H1N1) Market: Other (2018-2023) & (K Doses)
Figure 21. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022)
Figure 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application in 2022
Figure 23. Influenza Virus Vaccine (H1N1) Sales Market by Company in 2022 (K Doses)
Figure 24. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company in 2022
Figure 25. Influenza Virus Vaccine (H1N1) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2022
Figure 27. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 30. Americas Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 32. APAC Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 34. Europe Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 38. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 39. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 40. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 41. United States Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2022
Figure 46. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions in 2022
Figure 47. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 48. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 49. China Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 57. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 58. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 59. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 60. Germany Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1) in 2022
Figure 75. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
Figure 76. Industry Chain Structure of Influenza Virus Vaccine (H1N1)
Figure 77. Channels of Distribution
Figure 78. Global Influenza Virus Vaccine (H1N1) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Influenza Virus Vaccine (H1N1) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Virus Vaccine (H1N1) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intramuscular Vaccine
Figure 10. Product Picture of Nasal Spray Vaccine
Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2022
Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2023)
Figure 13. Influenza Virus Vaccine (H1N1) Consumed in 3 To 10 Years Old
Figure 14. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2018-2023) & (K Doses)
Figure 15. Influenza Virus Vaccine (H1N1) Consumed in 10 To 18 Years Old
Figure 16. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2018-2023) & (K Doses)
Figure 17. Influenza Virus Vaccine (H1N1) Consumed in Above 18 Years Old
Figure 18. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2018-2023) & (K Doses)
Figure 19. Influenza Virus Vaccine (H1N1) Consumed in Other
Figure 20. Global Influenza Virus Vaccine (H1N1) Market: Other (2018-2023) & (K Doses)
Figure 21. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022)
Figure 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application in 2022
Figure 23. Influenza Virus Vaccine (H1N1) Sales Market by Company in 2022 (K Doses)
Figure 24. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company in 2022
Figure 25. Influenza Virus Vaccine (H1N1) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2022
Figure 27. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 30. Americas Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 32. APAC Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 34. Europe Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 38. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 39. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 40. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 41. United States Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2022
Figure 46. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions in 2022
Figure 47. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 48. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 49. China Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 57. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 58. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 59. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 60. Germany Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Influenza Virus Vaccine (H1N1) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1) in 2022
Figure 75. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
Figure 76. Industry Chain Structure of Influenza Virus Vaccine (H1N1)
Figure 77. Channels of Distribution
Figure 78. Global Influenza Virus Vaccine (H1N1) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2024-2029)
